For the year ending 2025-12-31, CTRVP has $3,069,952 in assets. $402,405 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 1,828,062 | |||
| Prepaid expenses | 1,241,890 | |||
| Total current assets | 3,069,952 | |||
| Total assets | 3,069,952 | |||
| Accounts payable | 167,810 | |||
| Accrued expenses | 77,507 | |||
| Notes payable, current | 54,066 | |||
| Total current liabilities | 299,383 | |||
| Derivative financial instrumentswarrants | 103,022 | |||
| Total liabilities | 402,405 | |||
| Convertible preferred stock-Series APreferred Stock | 855,808 | |||
| Convertible preferred stock-Series CPreferred Stock | 839,320 | |||
| Common stock0.0001 par value per share 120,000,000 shares authorized, 11,620,317 and 139,168 shares issued and outstanding at december 31, 2025 and 2024, respectively | 1,162 | |||
| Additional paid-in capital | 247,060,568 | |||
| Accumulated other comprehensive income (loss) | 8,345 | |||
| Accumulated deficit | -246,097,656 | |||
| Total stockholders equity | 2,667,547 | |||
| Total liabilities and stockholders equity | 3,069,952 | |||
Hepion Pharmaceuticals, Inc. (CTRVP)
Hepion Pharmaceuticals, Inc. (CTRVP)